Lantern Pharma Inc. (NASDAQ:LTRN) Q3 2022 Earnings Call Transcript

Lantern Pharma Inc. (NASDAQ:LTRN) Q3 2022 Earnings Call Transcript November 7, 2022

Lantern Pharma Inc. beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.48.

Panna Sharma: Thank you, Nicole. Good afternoon, everyone. And welcome to our third quarter 2022 earnings call. Thank you for joining us this afternoon to hear about our third quarter results and corporate progress at Lantern. Lantern Pharma is at the leading edge of leveraging artificial intelligence, machine...